<DOC>
	<DOCNO>NCT00937872</DOCNO>
	<brief_summary>The primary objective study determine absolute bioavailability SRT2104 250 mg suspension , define intravenous pharmacokinetics SRT2104 . The secondary objective study assess potential systemic metabolite burden SRT2104 , provide plasma urine sample subsequent metabolite profile identification .</brief_summary>
	<brief_title>A Clinical Study Evaluate Pharmacokinetics Absolute Bioavailability SRT2104 Given 250mg Oral Suspension Intravenous Microdose 100 µg Carbon-14 Radio-labeled SRT2104 Healthy Male Subjects</brief_title>
	<detailed_description>This single centre , combine IV oral single dose , open-label study healthy male volunteer . Each subject receive follow formulation single study day : 1 . Regimen A : A single 10 mL oral dose 250 mg SRT2104 deliver suspension formulation ; 2 . Regimen B : A single intravenous dose 10 mL contain 100 µg ( 250 nCi , 9.25 kBq ) Carbon-14 radio-labeled SRT2104 , administer IV infusion 15 minute , start 2 hour 45 minute oral dose .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male ; Aged 1865 year ; Body Mass Index ( BMI ) 1835 kg/m2 ; Willing able participate whole study must provide write informed consent . Participation clinical research study involve investigational drug dosage form within previous 4 month ; Subjects previously enrol study ; Subjects ever seek advice refer GP counselor abuse misuse alcohol , non medical drug , medicinal drug substance abuse e.g . solvent ; Subjects admit current previous use Class A drug opiates , cocaine , ecstasy , lysergic acid diethylamide ( LSD ) intravenous amphetamine ( Subjects admit occasional past use cannabis exclude long negative drug abuse test abstinent least 12 month ; ) Positive drug abuse test result ( Section 7.8 ) ; Regular alcohol consumption male &gt; 21 unit per week ( 1 Unit = ½ pint beer , 25 mL shoot 40 % spirit 125 mL glass wine ) ; Current smoker smoke within last 12 month . A breath carbon monoxide read great 10 ppm screening ; Radiation exposure clinical trial , include present study diagnostic x ray exclude background radiation , exceed 5 mSv last twelve month 10 mSv last five year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study ; Clinically significant abnormal biochemistry , haematology urinalysis judge PI ( Section 7.8 ) History adverse reaction allergy study drug excipients , e.g . lactose . History significant allergy . If subject suffers hayfever must expect symptom study period ; Donation blood within previous three month ; Subjects exclude study consider PI risk transmitting , thorough blood body fluid , agent responsible acquire immunodeficiency syndrome ( AIDS ) sexually transmit disease hepatitis ; Positive HBV , HCV HIV result ; Subjects receive prohibit medication describe Section 6.10 ; Clinically significant medical history , examination find laboratory abnormality opinion Investigator make subject unsuitable include study ; Failure satisfy PI fitness participate reason .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>